Revolution Medicines wins EU committee backing for pancreatic cancer treatment
Oct 15 (Reuters) – A European Medicines Agency committee on Thursday recommended EU approval of Revolution Medicines’ drug for adults with metastatic pancreatic cancer, potentially offering patients in the bloc a new option for a disease with limited …